Introduction {#sec1}
============

Exercise-induced bronchoconstriction (EIB) describes increased sensitivity to exercise stimuli that cause airway narrowing *via* airway smooth muscle contraction ([@ref9]). Commonly associated with asthma, the presence and degree of EIB can be assessed in the laboratory using an exercise challenge test (EC), a stimulus that releases inflammatory mediators ([@ref6]; [@ref19]) *via* osmotic and thermal effects of respiratory water loss ([@ref6]).

Traditionally an EC is assessed using forced expiratory volume in 1 s (FEV~1~), where *a* ≥ 10% decline from baseline is considered positive ([@ref15]). Measurement is dependent on the patient's ability to perform maximal and repeatable efforts, which may be challenging for some and may independently alter airway resistance. The required deep inhalation is known to alter airway caliber in those with airway hyperresponsiveness, affecting airway resistance and therefore the sensitivity of FEV~1~ to detect EIB. In addition, other lung volume-related responses (such as hyperinflation) are not detectable by spirometry.

The use of oscillometry methods such as the forced oscillation technique (FOT) or the impulse oscillometry system can measure total respiratory system impedance encompassing the resistive, elastic, and inertial properties of the airways ([@ref14]). Increased airway resistance and more negative reactance have been identified in those with airway obstruction defined by spirometry and provide an insight into the behavior of the airway tree such as reduced airway caliber and increased ventilation inhomogeneity. A previous study using the impulse oscillometry system during EC in adults with probable EIB ([@ref8]) established the technique as repeatable, clinically relevant and to correlate with spirometry. FOT is performed during tidal breathing, which eliminates the need for forced maximal maneuvers required during spirometry. As such, the test is well tolerated by patients and suitable for serial measurement as required during a challenge test. The increasing availability of commercial FOT devices highlights the need to define the utility and any limitation to the adoption of this lung function modality in the clinical setting.

The impact of the increased minute ventilation (V~E~) and any change in the operating lung volume on FOT parameters during the challenge test has not been previously studied. Such patient factors could affect the reliability of the test. Dynamic hyperinflation has been previously described in both healthy subjects and those with airway hyperresponsiveness ([@ref4]). It is also known that FOT parameters are dependent on lung volume when measured in a resting steady state condition ([@ref14]; [@ref11]). As such, clinical practice recommendations suggest that measurement should be performed with the patient breathing at functional residual capacity. A stable respiratory rate, and consequently V~E~, is also recommended due to concern that an increased respiratory rate could affect signal-to-noise. Both of these factors, however, cannot be controlled following an exercise test since the test is associated with increased V~E~ and measurement is inherently not performed during steady state.

We hypothesized that measures of airway mechanics using FOT are sensitive in detecting EIB in comparison to forced maneuvers and are not confounded by the post exercise increase in V~E~. The aim of this investigation was (1) to compare changes in FOT and spirometry parameters post EC in people with asthma and healthy controls and (2) to investigate the rate of recovery and any effect of raised V~E~ following exercise on FOT parameters.

Methods {#sec2}
=======

Subjects and Study Design {#sec3}
-------------------------

This was a prospective study that was reviewed and approved by the Sydney Local Health District Human Ethics Review Board (HREC/15/CRGH/266, NSW, Australia) with written informed consent obtained from all subjects in accordance with the Declaration of Helsinki. Some data have been previously published in part ([@ref17]).

Subjects with asthma were recruited from a hospital-based airways disease clinic. A standard definition of current asthma was used; prior clinician diagnosis of asthma and symptoms or use of asthma medications within the last 12 months was used. All subjects were not permitted to have an upper respiratory tract infection within the past 4 weeks, any known cardiac disease or claustrophobia. Prior to all tests, subjects were asked to abstain from caffeine and exercise for at least 4 h, long-acting beta-agonists and/or inhaled corticosteroids for at least 48 h, tiotropium bromide or antihistamines for at least 72 h, and short-acting beta agonists for at least 12 h ([@ref3]). Healthy age matched controls (±1 SD of the mean age of the study group) who had no history of lung or cardiac disease were recruited for comparison *via* community advertisement.

At the initial visit, all subjects with asthma performed a mannitol challenge to determine the presence of airway hyperresponsiveness. At the second visit (which was within 1 week of the first visit), subjects sequentially completed the asthma control test, exhaled nitric oxide measurement and an exercise challenge designed to elicit EIB (EC). All tests were performed by experienced Scientific Officers in an accredited laboratory. All lung function measurement devices were successfully calibrated incorporating ambient conditions prior to each test.

Experimental Procedures {#sec4}
-----------------------

### Mannitol Challenge {#sec5}

A mannitol challenge (Aridol™, Pharmaxis, Frenchs Forest, NSW, Australia) was performed according to [@ref2]. The dose protocol consisted of 0, 5, 10, 20, 40, 80, 160, 160, and 160 mg mannitol delivered *via* osmohaler. Three FEV~1~ maneuvers were performed 60 s after each dose, and the highest was compared to that measured after the 0-mg capsule to calculate the percent decrease. The challenge was terminated when a 15% decrease in FEV~1~ was measured or a total cumulative dose of 635 mg had been given. Airway hyperresponsiveness to mannitol was defined as a 15% fall in FEV~1~ to a provoking cumulative dose of 635 mg or less (PD~15~).

### Asthma Control Test {#sec6}

Asthma control was determined using the patient-based five-item Asthma Control Test survey ([@ref12]). The subject completed the survey independently from the Scientific Officer, a score ≥ 20 indicates well controlled asthma.

### Exhaled Nitric Oxide {#sec7}

Exhaled nitric oxide was measured (CLD-88sp, Ecomedics, Dürnten, Switzerland) before any forced respiratory maneuvers according to consensus guidelines ([@ref1]). Following a full inhalation of zero nitric oxide (scrubbed) room air, the patient was instructed to exhale at 50 ± 5 ml s^−1^ until a plateau was measured. The recorded value was the mean of two values within 5% or mean of three values within 10% of each other. A value \>25 ppb was regarded as elevated.

### Exercise Challenge Test {#sec8}

An EC designed to elicit EIB was performed according to American Thoracic Society recommendations ([@ref15]). Subjects breathed room air on a cycle ergometer (VIAsprint 150p, Ergoline, Bitz, Germany) with a nose clip *in situ*. Continuous breath-by-breath gas analysis was measured, while the subject breathed through a mouthpiece connected to a metabolic cart (Oxycon Pro, Jaeger, Hoechberg, Germany). V~E~ was continuously monitored to ensure workload was titrated to elicit a target greater than 60% of the subjects estimated maximal voluntary ventilation (calculated as baseline FEV~1~ × 40) ([@ref3]; [@ref15]). The target workload was estimated using a validated algorithm and ramped over 3--4 min to achieve the target V~E~ for more than 4--5 min ([@ref7]).

Lung Function Measurements {#sec9}
--------------------------

FOT and then spirometry were performed prior to (baseline) and at 3-, 5-, 10-, 15- and 20-min post exercise.

### Forced Oscillation Technique {#sec10}

Respiratory system impedance to derive resistance (R~5~) and reactance (X~5~) at 5 Hz was assessed using the standardized FOT recommendations ([@ref14]) (tremoFlo software build 1.0.40.38, Thorasys, Montreal, Canada). Measurements were collected during 30-s of tidal breathing with the subject seated upright and with cheeks supported. Acceptability included at least three breaths free from artifact due to occlusion, leak or drift, or extreme (\>5 SD of mean) or negative resistance. The mean value generated from each measurement by the software was recorded.

### Spirometry {#sec11}

Spirometry to derive FEV~1~ and forced vital capacity was measured according to American Thoracic Society/European Respiratory society guidelines ([@ref10]) (Easy on-PC, ndd Medical Technologies, Zurich, Switzerland). The highest values of two repeatable, from three acceptable, efforts were recorded. Reference values were derived from the Global Lung Initiative ([@ref16]).

### Data Analysis {#sec12}

The primary measures of lung function were R~5~, X~5~, and FEV~1~ collected at each time point. EC response was expressed as the maximum fall in these values from baseline following exercise as a percentage of the baseline (pre-exercise) value. A ≥10% fall in FEV~1~ was considered positive ([@ref15]) and defined as "EC-positive." The values at the 20-min time point following EC as a percentage of the baseline were used to assess and compare the rate of recovery. At each time point, V~E~ was calculated from the product of mean tidal volume and the mean respiratory rate measured during the 30 s FOT recording.

Statistical Analysis {#sec13}
--------------------

Specialist statistical advice was received. Statistical analysis was performed using SPSS Statistics version 25 (IBM Corporation, Armonk, NY, USA) and graphs prepared using GraphPad Prism 7 (GraphPad Software Inc., La Jolla, California, USA). Values for FEV~1~ post exercise that remained higher than the pre-exercise value were censored as 0% fall and sequential FEV~1~, R~5~, X~5~, and V~E~ post EC as % change from baseline was compared across groups using a repeated measures ANOVA. A one-tailed Pearson's correlation investigated any association between R~5~, X~5~, FEV~1~, and V~E~ (including subdivisions of tidal volume and respiratory rate). Receiver operating characteristic curves were used to detect sensitivity and specificity for detecting a positive response to the EC as determined by FEV~1~ using FOT parameters. Group demographics, EC% maximum change, and recovery data were compared using an unpaired *t* test. Data are expressed as mean ± SD unless otherwise stated. A *p* \< 0.05 was considered significant.

Results {#sec14}
=======

Subjects and Baseline Lung Function Characteristics {#sec15}
---------------------------------------------------

Nineteen subjects with current asthma and 10 controls were studied. There were no differences in baseline demographics between groups ([Table 1](#tab1){ref-type="table"}). Most patients with asthma were mildly symptomatic with an ACT score of 19.7 ± 4.3 and had elevated exhaled nitric oxide (52 ± 46 ppb) as compared to controls (21 ± 13 ppb) that did not reach significance (*p* = 0.06) ([Table 2](#tab2){ref-type="table"}). At baseline, two thirds (12/19) of subjects with asthma had a normal FEV~1~/forced vital capacity ratio (above the lower limit of normal), and only one was mildly obstructed with a FEV~1~ below 80% of predicted. Two thirds (12/19) of subjects demonstrated airway hyperresponsiveness to mannitol with a PD~20FEV1~M of 165 ± 129 mg.

###### 

Subject baseline characteristics.

  Category                  Asthma                                        Healthy normal
  ------------------------- --------------------------------------------- ----------------
  Male:female               8:11                                          5:5
  Age (years)               28 ± 6                                        31 ± 5
  Height (cm)               169 ± 11                                      170 ± 9
  BMI (kg/cm^2^)            23.8 ± 3.1                                    24.0 ± 2.9
  FEV~1~ (L)                3.46 ± 0.75                                   3.51 ± 0.65
  FEV~1~ (%predicted)       93 ± 11                                       99 ± 13
  FEV~1~/FVC ratio          0.77 ± 0.07[\*](#tfn1){ref-type="table-fn"}   0.85 ± 0.04
  R~5~ (cm H~2~O s L^−1^)   3.49 ± 1.21                                   2.90 ± 1.02
  X~5~ (cm H~2~O s L^−1^)   −1.20 ± 0.50                                  −1.00 ± 0.35

*Data are mean ± SD. BMI, body mass index; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; R~5~, resistance at 5 Hz; X~5~, reactance at 5 Hz*.

*Vs. control (*p* \< 0.02), unpaired *t* test*.

###### 

Lung function and exercise response.

                                             Asthma                                                                              Controls                                  
  ------------------------------------------ ----------------------------------------------------------------------------------- ----------------------------------------- -------------
  Subject (*n*)                              5                                                                                   14                                        10
  ACT score                                  18 ± 6                                                                              20 ± 3                                    ---
  eNO (ppb)                                  73 ± 46[^\*^](#tfn2){ref-type="table-fn"}                                           43 ± 45                                   21 ± 13
  Mannitol positive                          100%                                                                                50%                                       ---
  PD~15~M                                    128 ± 101                                                                           213 ± 136                                 ---
  FEV~1~ (%max change from baseline)         20 ± 13[\*](#tfn2){ref-type="table-fn"},[^†^](#tfn3){ref-type="table-fn"}           4 ± 3[^\*^](#tfn2){ref-type="table-fn"}   1 ± 1
  R~5~ (%max change from baseline)           82 ± 105[^\*^](#tfn2){ref-type="table-fn"}^,^[^†^](#tfn3){ref-type="table-fn"}      16 ± 16                                   5 ± 10
  X~5~ (absolute max change from baseline)   1.76 ± 1.71[^\*^](#tfn2){ref-type="table-fn"}^,^[^†^](#tfn3){ref-type="table-fn"}   0.11 ± 0.26                               0.14 ± 0.22
  ***Exercise response***                                                                                                                                                  
  Watts                                      126 ± 40                                                                            108 ± 36                                  113 ± 22
  V~E~ (L min^−1^)                           89 ± 23                                                                             78 ± 13                                   78 ± 11
  %max predicted HR                          88 ± 4                                                                              88 ± 5                                    87 ± 4
  ***Post exercise response***                                                                                                                                             
  Max V~E~                                                                                                                                                                 
  L min^−1^                                  25 ± 9                                                                              26 ± 7                                    23 ± 8
  %change from baseline                      109 ± 68                                                                            101 ± 42                                  97 ± 70
  Max RR                                                                                                                                                                   
  bpm                                        9 ± 4                                                                               9 ± 1                                     9 ± 3
  %change from baseline                      17 ± 25                                                                             28 ± 26                                   36 ± 42
  Max V~T~                                                                                                                                                                 
  L                                          1.78 ± 0.57                                                                         1.65 ± 0.61                               1.43 ± 0.70
  \% change from baseline                    97 ± 53                                                                             76 ± 44                                   55 ± 33

*Data are mean ± SD*.

*EC, exercise challenge; ACT, asthma control test; eNO, exhaled nitric oxide; PD~15~M, provoking cumulative Mannitol dose for a 15% fall in FEV~1~; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; R~5~, resistance at 5 Hz; X~5~, reactance at 5 Hz; V~E~, minute ventilation; HR, heart rate; RR, respiratory rate; V~T~, tidal volume*.

*Vs. control*.

*Vs. EC negative, unpaired *t* test, *p* \< 0.02*.

Exercise Challenge Test {#sec16}
-----------------------

Laboratory ambient conditions were 49 ± 12% relative humidity and 22 ± 1°C. Average V~E~ measured during the EC was 81 ± 15 L min^−1^ that equated with 59 ± 6% of the estimated maximal voluntary ventilation, corresponding with an average heart rate of 87 ± 4% predicted maximum. There was no difference between groups in the exercise response, including ventilatory parameters during or following exercise ([Table 2](#tab2){ref-type="table"}).

Five of the 19 subjects with asthma were EC positive. The R~5~ and X~5~ responses following EC were different in this group (max %change 92 ± 100% and 178 ± 188%) as compared to EC-negative asthma and healthy normal subjects (max %change 7 ± 7% and 16 ± 14%, *p* \< 0.02) ([Figure 1](#fig1){ref-type="fig"}). The % recovery to baseline from maximum change at 20 min post EC was greater for X~5~ (*p* = 0.03) but similar between R~5~ and FEV~1~ (65 ± 21%, 43 ± 35%, and 26 ± 16%, respectively). Following EC, max % change FEV~1~ correlated with R~5~ (*r* = 0.92, *p* = 0.001) and X~5~ (*r* = 0.91, *p* = 0.001) across all subjects.

![Mean ± SD percent change from baseline in forced expiratory volume in 1 s (FEV~1~), respiratory resistance (R~5~), and reactance (X~5~) at 5 Hz following an exercise challenge test in 19 subjects with current asthma that responded by FEV~1~ criteria (EC positive asthma, *n* = 5), did not respond (EC negative asthma, *n* = 14) and 10 healthy normals. \*Repeated measures ANOVA, *p* \< 0.02.](fphys-10-01411-g001){#fig1}

V~E~ was significantly elevated post EC (24.6 ± 7.3 L) as compared to baseline (12.6 ± 3.5 L, *p* = 0.0001), with a max change of 101 ± 55%. This was *via* a significant increase in both tidal volume (72 ± 43% max change) and respiratory rate (29 ± 32% max change) (*p* \< 0.0001). The change in ventilatory parameters did not relate to the % change R~5~ ([Figure 2](#fig2){ref-type="fig"}) or X~5~ across all subjects or in those that were EC positive (*r* \< 0.4, *p* \> 0.1). The ventilatory responses during and following exercise were similar between groups ([Table 2](#tab2){ref-type="table"}).

![The correlation between minute ventilation (V~E~) and airway resistance at 5 Hz (R~5~) as a percent change from baseline at four sequential time points following an exercise challenge in 19 subjects with current asthma that responded by spirometry criteria (EC positive asthma, *n* = 5), did not respond (EC negative asthma, *n* = 14) and 10 healthy normals. *r*, Pearson's correlation.](fphys-10-01411-g002){#fig2}

The sensitivity and specificity of R~5~ and X~5~ to detect a positive response to the EC as determined by FEV~1~ are presented in [Figure 3](#fig3){ref-type="fig"}. R~5~ had a sensitivity and specificity of 80 and 86%, X~5~ had a sensitivity and specificity of 80 and 93%, respectively. A cut-off of 27% increase in R~5~ and 47% decrease in X~5~ yielded optimal sensitivity and specificity for a positive response as detected using FEV~1~.

![Receiver operator characteristic curves of the sensitivity and specificity of resistance (R~5~) and reactance (X~5~) at 5 z for detecting a positive response to an exercise challenge by spirometry criteria. Reference (solid line), AUC, area under the curve.](fphys-10-01411-g003){#fig3}

Discussion {#sec17}
==========

In patients with asthma, measurement of respiratory system impedance using the FOT identified EIB during an exercise challenge when compared to the accepted FEV~1~ criteria. Furthermore, the change in resistance and reactance was not unduly influenced by the change in V~E~ or respiratory rate following exercise. The results support the measurement of EIB in the laboratory using FOT as an alternative to spirometry.

The potential effect of raised respiratory rate or V~E~ post exercise has not been previously addressed. Standard FOT measurement requires quiet spontaneous resting breathing at functional residual capacity ([@ref14]), yet variable changes in this value post exercise and/or due to bronchoconstriction can potentially alter measures of impedance ([@ref4]; [@ref18]). A single previous publication reported similar strong agreement between spirometry and impedance measured with impulse oscillometry system in an uncontrolled group of adult subjects with probable EIB ([@ref8]). We felt it important to determine any influence of alterations in V~E~, either *via* respiratory rate or tidal volume post EC, on repeated FOT measures. V~E~ remained highly elevated following exercise during the data collection period, predominately from an expansion of tidal volume. This was similarly seen across groups of those with responsive asthma, non-responsive asthma and healthy controls. Reassuringly, there was no relationship between the FOT parameters of interest and V~E~, respiratory rate or tidal volume.

FOT is highly sensitive to changes in airway function during an exercise challenge test. The change in resistance and reactance following the EC predictably tracked with the change in FEV~1~. There was a clear separation in these measurements between subjects that were responsive according to the accepted FEV~1~ cut-off as compared to non-responsive asthma and control subjects. Indeed, both R~5~ and X~5~ were highly sensitive and specific for a positive EC. The optimal derived cut-offs for R~5~ and X~5~ to detect a 10% fall in FEV~1~ were 27 and 47%, respectively. Interestingly, these bronchoconstrictor cut-off values are similar in magnitude to previously published cut-offs for bronchodilator reversibility (32% change for R~5~ and 44% change for X~5~) ([@ref13]).

The observation that changes in resistance related closely to changes in FEV~1~ is physiologically consistent since both measurements are influenced by airway caliber. Reactance, on the other hand, relates to the stiffness of the respiratory system as measured during tidal breathing and is dependent on the volume of accessible lung during the measurement ([@ref11]). The development of bronchoconstriction during a challenge test results in a more heterogeneous lung with physiologically different lung units and more disparate time constants contributing to the overall impedance measured at the mouth. Hence, the more negative reactance that develops during challenge tests is likely a reflection of the narrowing and/or airway closure that develops in the distal airways.

The change in reactance and resistance during a challenge test provides physiologically relevant insights into airway behavior. It is noteworthy that reactance recovered faster than resistance or FEV~1~ post exercise. We hypothesize that this early recovery in X~5~ may reflect early functional recovery in the distal airway compartment before a measured improvement is seen in the indices that reflect more proximal airway caliber. The exact mechanisms are beyond the scope of this study but likely reflect a complex interaction of changes in the small airway caliber, altered transmural forces, and parenchymal tethering. Data collection in this study was terminated at 20-min post EC as recommended by clinical guidelines. Though not the primary objective of this study, a longer period may have allowed for further analysis of the time-dependent recovery of the various parameters.

Reassuringly, all subjects with a positive EC response using FEV~1~ criteria also exhibited a change using FOT. This indicates that FOT measurement can be safely performed during these tests without concerns for unrecognized bronchoconstriction.

There are some limitations to our study. Large variability was seen in the EC responders in R~5~ and X~5~; however, this was similarly observed with FEV~1~, and the changes were strongly correlated. As the EC is not a "dose response" challenge, inter-subject variability in airway response across a broad selection of subjects with "current asthma" is not unexpected ([@ref5]). The higher than ideal ambient humidity of the laboratory, though still within the acceptable range ([@ref7]), may have contributed to an underestimation of EIB. Nevertheless, this should not confound the current results since the analysis compared the various lung function parameters during the EC irrespective of the severity of EIB. The maximal inhalation required prior to the measurement of FEV~1~ can alter airway resistance, and it follows that FOT measured during tidal breathing may be more sensitive in detecting EIB. While FOT was measured prior to spirometry at all time points, it is important to repeat this study with and without FEV~1~ measurement as a validation study to determine repeatability of the test and confirm cut-off thresholds. Our cohort has small subject numbers, but the results are novel using a commercially available FOT device and suggest that FOT may be a clinically appropriate lung function measurement during a challenge test. Clearly, there is a need to derive clinically relevant cut points for more widespread uptake of FOT during challenge testing.

In conclusion, our results show that FOT measures detected bronchial reactivity to exercise as defined by a change in FEV~1~. Importantly, the FOT values are not confounded acutely by the raised minute ventilation post exercise. Hence, FOT measurement may be an alternative lung function test for the assessment of exercise-induced bronchoconstriction. It could be most useful in subjects who cannot perform spirometry to a satisfactory standard in the period after exercise or in whom deep breath-induced bronchoconstriction or bronchodilatation is problematic.
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:   exercise challenge test
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X~5~
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